Cardlytics (CDLX) Tops Q3 EPS by 42c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), $0.42 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $67.06 million versus the consensus estimate of $57.71 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• BrandPilot AI closes final tranche of private placement at $854,500
• Trex (TREX) PT Raised to $60; Truist: 'We expect the stock to move up notably on this result'